Cargando…
Prediction of cognitive impairment via deep learning trained with multi-center neuropsychological test data
BACKGROUND: Neuropsychological tests (NPTs) are important tools for informing diagnoses of cognitive impairment (CI). However, interpreting NPTs requires specialists and is thus time-consuming. To streamline the application of NPTs in clinical settings, we developed and evaluated the accuracy of a m...
Autores principales: | Kang, Min Ju, Kim, Sang Yun, Na, Duk L., Kim, Byeong C., Yang, Dong Won, Kim, Eun-Joo, Na, Hae Ri, Han, Hyun Jeong, Lee, Jae-Hong, Kim, Jong Hun, Park, Kee Hyung, Park, Kyung Won, Han, Seol-Heui, Kim, Seong Yoon, Yoon, Soo Jin, Yoon, Bora, Seo, Sang Won, Moon, So Young, Yang, YoungSoon, Shim, Yong S., Baek, Min Jae, Jeong, Jee Hyang, Choi, Seong Hye, Youn, Young Chul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873409/ https://www.ncbi.nlm.nih.gov/pubmed/31752864 http://dx.doi.org/10.1186/s12911-019-0974-x |
Ejemplares similares
-
A Multicentre, Randomised, Open-Label, Prospective Study to Estimate the Add-On Effects Of Memantine as Ebixa(®) Oral Pump (Solution) on Language in Patients with Moderate to Severe Alzheimer’s Disease Already Receiving Donepezil (ROMEO-AD)
por: Kim, Hee-Jin, et al.
Publicado: (2023) -
Survival in Korean Patients with Frontotemporal Dementia Syndrome: Association with Behavioral Features and Parkinsonism
por: Jung, Na-Yeon, et al.
Publicado: (2022) -
Age-Specific Cutoff Scores on a T1-Weighted Axial Medial Temporal-Lobe Atrophy Visual Rating Scale in Alzheimer's Disease Using Clinical Research Center for Dementia of South Korea Data
por: Choi, Gyeong Seon, et al.
Publicado: (2018) -
Efficacy and safety of GV1001 in patients with moderate-to-severe Alzheimer’s disease already receiving donepezil: a phase 2 randomized, double-blind, placebo-controlled, multicenter clinical trial
por: Koh, Seong-Ho, et al.
Publicado: (2021) -
Effects of GV1001 on Language Dysfunction in Patients With Moderate-to-Severe Alzheimer’s Disease: Post Hoc Analysis of Severe Impairment Battery Subscales
por: Kwon, Hyuk Sung, et al.
Publicado: (2023)